A cross-sectional study of prescription pattern of drugs used in the treatment of acne vulgaris at a tertiary care hospital in India

Mahesh Namdeo Belhekar; Tejal C Patel; Prasad R Pandit; Kiran A Bhave; Priyansh P Nathani; Meena Makhecha

doi:10.5455/njppp.2023.13.05223202223052022

2023, Vol: 13, Issue: 3

13/3Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

Authorship Declaration

« Previous Article

Original Research

Natl J Physiol Pharm Pharmacol. 2023; 13(1): 32-36

doi: 10.5455/njppp.2023.13.05223202223052022

A cross-sectional study of prescription pattern of drugs used in the treatment of acne vulgaris at a tertiary care hospital in India

Mahesh Namdeo Belhekar, Tejal C Patel, Prasad R Pandit, Kiran A Bhave, Priyansh P Nathani, Meena Makhecha.

Abstract
Background: Acne vulgaris is a common dermatological disease affecting 85% of adolescents across the globe with 40% having persistent acne well into their twenties. Acne and post-inflammatory hyperpigmentation often negatively impact self-perception, social interactions, and affect quality of life scores in adolescents.

Aims and Objectives: The aim of the study was to evaluate the prescription pattern of drugs used in the treatment of acne to find out the current prescribing practices relating to comprehensive care being provided at a tertiary care hospital.

Materials and Methods: This was a cross-sectional and observational study conducted after getting approval of Institutional Ethics Committee on 135 patients of either sex and age more than 12 and ≤40 years diagnosed with acne.

Results: Data of 135 prescriptions of acne patients were analyzed. Most patients presented with Grade 2 (n = 56; 41.5%) acne followed by Grade 3 acne (n = 40; 29.6%) patients. The average numbers of drugs per prescription was 3.87. Out of 522 drugs prescribed, 436 (83.5%) were topical and 86 (16.5%) were oral formulations. Among topical formulations, most frequently prescribed drug was tretinoin prescribed to 92 (68.1%) patients whereas, doxycycline was the most preferred oral antibiotic prescribed to 66 (48.9%) patients.

Conclusion: The study revealed that drugs prescribed were found to be in accordance with the treatment guidelines proposed by Indian dermatologists and American Academy of Dermatology.

Key words: Acne vulgaris; Adolescents; Prescription Pattern; Tretinoin

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Mahesh Namdeo Belhekar Articles by Tejal C Patel Articles by Prasad R Pandit Articles by Kiran A Bhave Articles by Priyansh P Nathani Articles by Meena Makhecha
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Belhekar MN, Patel TC, Pandit PR, Bhave KA, Nathani PP, Makhecha M. A cross-sectional study of prescription pattern of drugs used in the treatment of acne vulgaris at a tertiary care hospital in India. Natl J Physiol Pharm Pharmacol. 2023; 13(1): 32-36. doi:10.5455/njppp.2023.13.05223202223052022

Web Style

Belhekar MN, Patel TC, Pandit PR, Bhave KA, Nathani PP, Makhecha M. A cross-sectional study of prescription pattern of drugs used in the treatment of acne vulgaris at a tertiary care hospital in India. https://www.njppp.com/?mno=41059 [Access: March 01, 2023]. doi:10.5455/njppp.2023.13.05223202223052022

AMA (American Medical Association) Style

Belhekar MN, Patel TC, Pandit PR, Bhave KA, Nathani PP, Makhecha M. A cross-sectional study of prescription pattern of drugs used in the treatment of acne vulgaris at a tertiary care hospital in India. Natl J Physiol Pharm Pharmacol. 2023; 13(1): 32-36. doi:10.5455/njppp.2023.13.05223202223052022

Vancouver/ICMJE Style

Belhekar MN, Patel TC, Pandit PR, Bhave KA, Nathani PP, Makhecha M. A cross-sectional study of prescription pattern of drugs used in the treatment of acne vulgaris at a tertiary care hospital in India. Natl J Physiol Pharm Pharmacol. (2023), [cited March 01, 2023]; 13(1): 32-36. doi:10.5455/njppp.2023.13.05223202223052022

Harvard Style

Belhekar, M. N., Patel, . T. C., Pandit, . P. R., Bhave, . K. A., Nathani, . P. P. & Makhecha, . M. (2023) A cross-sectional study of prescription pattern of drugs used in the treatment of acne vulgaris at a tertiary care hospital in India. Natl J Physiol Pharm Pharmacol, 13 (1), 32-36. doi:10.5455/njppp.2023.13.05223202223052022

Turabian Style

Belhekar, Mahesh Namdeo, Tejal C Patel, Prasad R Pandit, Kiran A Bhave, Priyansh P Nathani, and Meena Makhecha. 2023. A cross-sectional study of prescription pattern of drugs used in the treatment of acne vulgaris at a tertiary care hospital in India. National Journal of Physiology, Pharmacy and Pharmacology, 13 (1), 32-36. doi:10.5455/njppp.2023.13.05223202223052022

Chicago Style

Belhekar, Mahesh Namdeo, Tejal C Patel, Prasad R Pandit, Kiran A Bhave, Priyansh P Nathani, and Meena Makhecha. "A cross-sectional study of prescription pattern of drugs used in the treatment of acne vulgaris at a tertiary care hospital in India." National Journal of Physiology, Pharmacy and Pharmacology 13 (2023), 32-36. doi:10.5455/njppp.2023.13.05223202223052022

MLA (The Modern Language Association) Style

Belhekar, Mahesh Namdeo, Tejal C Patel, Prasad R Pandit, Kiran A Bhave, Priyansh P Nathani, and Meena Makhecha. "A cross-sectional study of prescription pattern of drugs used in the treatment of acne vulgaris at a tertiary care hospital in India." National Journal of Physiology, Pharmacy and Pharmacology 13.1 (2023), 32-36. Print. doi:10.5455/njppp.2023.13.05223202223052022

APA (American Psychological Association) Style

Belhekar, M. N., Patel, . T. C., Pandit, . P. R., Bhave, . K. A., Nathani, . P. P. & Makhecha, . M. (2023) A cross-sectional study of prescription pattern of drugs used in the treatment of acne vulgaris at a tertiary care hospital in India. National Journal of Physiology, Pharmacy and Pharmacology, 13 (1), 32-36. doi:10.5455/njppp.2023.13.05223202223052022

Author Login Reviewer Login About Publisher Editorial Policies Peer Review Policy Editorial & Peer Review Process Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of Concern Self-Archiving Policies Statement of Informed Consent Advertising Policy Terms of Use License Information Copyright Information



Copyright © 2023 National Journal of Physiology, Pharmacy and Pharmacology All Rights Reserved. Subject to change without notice from or liability to National Journal of Physiology, Pharmacy and Pharmacology. For best results, please use Internet Explorer or Google Chrome	Contact Information Publisher publishernjppp@gmail.com Editorial query editornjppp1@gmail.com MOB - 8780040272

Contact Information

How to cite this article